Here, we report a patient with a high-grade malignant neoplasm, most compatible with carcinoma, involving the lung and mediastinum in which we identify a novel CLTC::RPS6KB1 fusion as the likely driver mutation. This evidence concerns the gene CLTC and carcinoma.